We are live on
!
Find out more
Vanguard Portfolio Management Portfolio holdings
AUM
$2.22T
This Fund
S&P 500
This Quarter
Est. Return
+25.71%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.22T
AUM Growth
+$305B
(+16%)
Cap. Flow
+$19.5B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
21.57%
Holding
3,286
New
192
Increased
2,077
Reduced
864
Closed
145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$1.74B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$1.66B |
| 3 |
NVIDIA
NVDA
|
+$1.58B |
| 4 |
Micron Technology
MU
|
+$1.23B |
| 5 |
Devon Energy
DVN
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$2.45B |
| 2 |
Seagate
STX
|
+$2.36B |
| 3 |
Western Digital
WDC
|
+$1.98B |
| 4 |
Honeywell
HON
|
+$1.74B |
| 5 |
Corning
GLW
|
+$1.7B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.19% |
| 2 | Financials | 11.67% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 9.73% |
| 5 | Consumer Discretionary | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Neurogene
NGNE
$760M
| $3.01M | ﹤0.01% |
95,601
+30,521
| +47% | +$840K |
|
2602
Foster
FSTR
$399M
| $3M | ﹤0.01% |
66,408
+9,109
| +16% | +$340K |
|
2603
American Battery Technology Co
ABAT
$318M
| $3M | ﹤0.01% |
1,059,917
-100,862
| -9% | -$323K |
|
2604
Icon
ICLR
$13.4B
| $2.99M | ﹤0.01% |
17,207
+171
| +1% | +$21.8K |
|
2605
Franklin Covey
FC
$226M
| $2.98M | ﹤0.01% |
121,321
+7,657
| +7% | +$175K |
|
2606
Caledonia Mining Corp
CMCL
$482M
| $2.97M | ﹤0.01% |
155,475
-13,284
| -8% | -$302K |
|
|
WYFI
2607
WhiteFiber Inc
WYFI
$822M
| $2.96M | ﹤0.01% |
76,309
+11,341
| +17% | +$274K |
|
2608
Park-Ohio Holdings
PKOH
$656M
| $2.96M | ﹤0.01% |
77,068
+10,996
| +17% | +$338K |
|
|
CTNM
2609
Contineum Therapeutics
CTNM
$603M
| $2.96M | ﹤0.01% |
+180,302
| New | +$2.36M |
|
2610
Codexis
CDXS
$173M
| $2.95M | ﹤0.01% |
1,307,171
+427,832
| +49% | +$1.07M |
|
2611
Korro Bio
KRRO
$191M
| $2.95M | ﹤0.01% |
223,551
+74,992
| +50% | +$932K |
|
2612
Regional Management Corp
RM
$307M
| $2.95M | ﹤0.01% |
71,481
+18,757
| +36% | +$688K |
|
|
FVR
2613
FrontView REIT
FVR
$486M
| $2.94M | ﹤0.01% |
145,427
+26,969
| +23% | +$486K |
|
2614
Designer Brands
DBI
$291M
| $2.94M | ﹤0.01% |
504,460
+63,020
| +14% | +$443K |
|
2615
Atea Pharmaceuticals
AVIR
$430M
| $2.93M | ﹤0.01% |
630,185
+72,606
| +13% | +$361K |
|
2616
Immix Biopharma
IMMX
$937M
| $2.93M | ﹤0.01% |
+283,711
| New | +$2.63M |
|
2617
Akebia Therapeutics
AKBA
$255M
| $2.89M | ﹤0.01% |
2,533,977
+318,536
| +14% | +$379K |
|
|
MMED
2618
MiniMed Group Inc
MMED
$5.67B
| $2.89M | ﹤0.01% |
+193,047
| New | +$2.54M |
|
2619
Contango Silver & Gold Inc
CTGO
$680M
| $2.86M | ﹤0.01% |
181,434
+3,457
| +2% | +$71.2K |
|
2620
Fulcrum Therapeutics
FULC
$294M
| $2.86M | ﹤0.01% |
782,144
+182,765
| +30% | +$1.11M |
|
2621
Clearwater Paper
CLW
$350M
| $2.86M | ﹤0.01% |
182,460
-47,861
| -21% | -$721K |
|
2622
Lexeo Therapeutics
LXEO
$415M
| $2.86M | ﹤0.01% |
613,826
+36,634
| +6% | +$198K |
|
2623
Civeo
CVEO
$358M
| $2.85M | ﹤0.01% |
81,504
+69,731
| +592% | +$2.25M |
|
|
WLTH
2624
Wealthfront Corp
WLTH
$1.37B
| $2.85M | ﹤0.01% |
318,475
+112,680
| +55% | +$1.17M |
|
2625
Forte Biosciences
FBRX
$1.63B
| $2.84M | ﹤0.01% |
+133,771
| New | +$3.17M |
|
Similar funds
Vanguard Portfolio Management's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Portfolio Management held 3,286 positions worth $2.22T, up 16% from $1.91T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Vanguard Portfolio Management's Q2 2026 filing shows 192 new, 2,077 increased, 864 reduced and 145 closed positions. Its largest new stake was SpaceX: 10,225,389 shares worth $1.75B. The largest sale was Marvell Technology, an estimated $2.45B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 29% a quarter earlier, followed by Financials and Industrials.
- Vanguard Portfolio Management's largest Q2 2026 buy was SpaceX: 10,225,389 shares worth $1.75B.
- Vanguard Portfolio Management added most to NVIDIA in Q2 2026, an estimated $1.58B increase.
- Vanguard Portfolio Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $2.45B.
- Vanguard Portfolio Management fully exited Coterra Energy in Q2 2026, selling an estimated $1.3B.
- Vanguard Portfolio Management's ten largest holdings make up 22% of its $2.22T portfolio in Q2 2026.
- Vanguard Portfolio Management opened 192 new positions and closed 145 in Q2 2026.
- Vanguard Portfolio Management's portfolio value rose 16% quarter-over-quarter to $2.22T.
Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.